Long-term treatment of symptomatic heart failure
Details for Australian Patent Application No. 2009278317 (hide)
International Classifications
Event Publications
17 February 2011 PCT application entered the National Phase
PCT publication WO2010/015335 Priority application(s): WO2010/015335
31 March 2011 Corrigenda
PCT applications that have entered the National Phase - Name Index Under the name Spa Societya' Prodottie Antibiotici S.P.A.; Sixterpharma srl, Application No. 2009278317, Under INID (71) correct the applicant name to Spa Societa' Prodotti Antibiotici S.p.A.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2009278319-Use of azoles for increasing the abiotic stress resistance of plants or plant parts
2009278306-Quinuclidine carbonate derivatives and medicinal composition thereof
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser